Frontlight ResearchEarly access
Trial site
Friedrich Baur Institute An Der Neurologischen Klinik Und Poliklinik
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Myotonic dystrophy3 trials
- Epilepsy1 trial
- Fabry disease1 trial
- Hearing loss1 trial
- Mitochondrial disease1 trial
- Pompe disease1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 1/23 trials
- Phase 22 trials
- Phase 31 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Vertex Pharmaceuticals Incorporated2 trials
- Dyne Therapeutics1 trial
- Omeicos Therapeutics GmbH1 trial
- Sanofi1 trial
- Spark Therapeutics, Inc.1 trial
Running trials
Enrolling by invitation
A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I
Active, not recruiting
A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myotonic dystrophy2 recruiting
- Pompe disease1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026